New asthma drug enters first human testing phase
NCT ID NCT07281274
Summary
This early-stage study aims to test the safety and effects of a new investigational drug called ADO-5030 in people with asthma. Researchers will enroll 36 adults with mild-to-moderate asthma to see how the drug affects their breathing during a controlled airway challenge test. The main goal is to understand if the drug is safe and how it behaves in the body, not to provide treatment benefits to participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Virginia
Charlottesville, Virginia, 22904, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.